Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.96375
-0.0011 (-0.12%)
Aug 14, 2026, 10:16 AM EDT - Market open
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $184.03 million as of August 14, 2026. Its market cap has increased by 84.09% in one year.
Market Cap
184.03M
Enterprise Value
174.46M
1-Year Change
84.09%
Ranking
Category
Stock Price
$0.96
ChartMarket Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $184.03M, a decrease of -64.21%. That is a compound annual growth rate of -19.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 184.03M | 28.78% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RxSight | 293.65M |
| Profound Medical | 255.10M |
| AVITA Medical | 251.13M |
| Neuronetics | 244.58M |
| InfuSystem Holdings | 243.79M |
| Quantum-Si incorporated | 182.35M |
| Owlet | 168.50M |
| Inogen | 154.19M |